These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 745402)
1. Steroidal inhibitors of prostatic 5alpha-reductase: structure-activity relationships. Dupuy GM; Roberts KD; Bleau G; Chapdelaine A J Steroid Biochem; 1978 Nov; 9(11):1043-7. PubMed ID: 745402 [No Abstract] [Full Text] [Related]
2. Studies on a 5 alpha-reductase inhibitor and their therapeutic implications. Petrow V; Lack L Prog Clin Biol Res; 1981; 75B():283-97. PubMed ID: 7323098 [No Abstract] [Full Text] [Related]
3. 5alpha-reduction of an anti-androgen TSAA-291, 16beta-ethyl-17beta-hydroxy-4-estren-3-one, by nuclear 5alpha-reductase in rat prostates. Sudo K; Yoshida K; Akinaga Y; Nakayama R Steroids; 1981 Jul; 38(1):55-71. PubMed ID: 7292540 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of prostatic 5alpha-reductase and 3alpha-hydroxysteroid dehydrogenase by two antiandrogens. Dupuy GM; Roberts KD; Bleau G; Chapdelaine A J Steroid Biochem; 1977 Nov; 8(11):1145-51. PubMed ID: 926781 [No Abstract] [Full Text] [Related]
5. Inhibitory effects of some steroidal 6-methylene derivatives on 5 alpha-reductase activity in human and rat prostate. Kadohama N; Petrow V; Lack L; Sandberg AA J Steroid Biochem; 1983 May; 18(5):551-8. PubMed ID: 6855230 [TBL] [Abstract][Full Text] [Related]
6. 12. Androgens: Pharmacodynamics and antagonists. Biochemical and biological studies with 4-aza-steroidal 5 alpha-reductase inhibitors. Liang T; Rasmusson GH; Brooks JR J Steroid Biochem; 1983 Jul; 19(1A):385-90. PubMed ID: 6887871 [TBL] [Abstract][Full Text] [Related]
7. Species differences in prostatic steroid 5 alpha-reductases of rat, dog, and human. Liang T; Cascieri MA; Cheung AH; Reynolds GF; Rasmusson GH Endocrinology; 1985 Aug; 117(2):571-9. PubMed ID: 4017948 [TBL] [Abstract][Full Text] [Related]
8. Prostatic cancer--II. Inhibitors of rat prostatic 4-ene-3-ketosteroid 5 alpha-reductase derived from 6-methylene-4-androsten-3-ones. Petrow V; Wang YS; Lack L; Sandberg A; Kadohama N; Kendle K J Steroid Biochem; 1983 Oct; 19(4):1491-502. PubMed ID: 6645489 [TBL] [Abstract][Full Text] [Related]
9. Prostatic cancer. I. 6-Methylene-4-pregnen-3-ones as irreversible inhibitors of rat prostatic delta 4-3 ketosteroid 5 alpha-reductase. Petrow V; Wang Y; Lack L; Sandberg A Steroids; 1981 Aug; 38(2):121-40. PubMed ID: 7303026 [TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5alpha-reductase inhibitors. Bratoeff E; Cabeza M; Pérez-Ornelas V; Recillas S; Heuze I J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):275-81. PubMed ID: 18644453 [TBL] [Abstract][Full Text] [Related]
11. Effects of some novel inhibitors of C17,20-lyase and 5alpha-reductase in vitro and in vivo and their potential role in the treatment of prostate cancer. Nnane IP; Kato K; Liu Y; Lu Q; Wang X; Ling YZ; Brodie A Cancer Res; 1998 Sep; 58(17):3826-32. PubMed ID: 9731491 [TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of prostatic tumor 5 alpha-reductase by a 4-methyl-4-azasteroid. Kadohama N; Karr JP; Murphy GP; Sandberg AA Cancer Res; 1984 Nov; 44(11):4947-54. PubMed ID: 6488158 [TBL] [Abstract][Full Text] [Related]
13. Properties of testosterone 5 -reductase of purified nuclear fraction from ventral prostate of rats. Shimazaki J; Horaguchi T; Oki Y; Shida K Endocrinol Jpn; 1971 Apr; 18(2):179-87. PubMed ID: 4105278 [No Abstract] [Full Text] [Related]
14. Azasteroids as inhibitors of rat prostatic 5 alpha-reductase. Rasmusson GH; Reynolds GF; Utne T; Jobson RB; Primka RL; Berman C; Brooks JR J Med Chem; 1984 Dec; 27(12):1690-701. PubMed ID: 6502599 [TBL] [Abstract][Full Text] [Related]
15. Preparation of 20-(hydroxymethyl)-4-methyl-4-aza-2-oxa-5 alpha-pregnan-3-one as an inhibitor of testosterone 5 alpha-reductase. Weintraub PM; Blohm TR; Laughlin M J Med Chem; 1985 Jun; 28(6):831-3. PubMed ID: 4009607 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of androgen synthesis in human testicular and prostatic microsomes and in male rats by novel steroidal compounds. Nnane IP; Kato K; Liu Y; Long BJ; Lu Q; Wang X; Ling YZ; Brodie A Endocrinology; 1999 Jun; 140(6):2891-7. PubMed ID: 10342882 [TBL] [Abstract][Full Text] [Related]
18. A novel class of inhibitors for human steroid 5alpha-reductase: synthesis and biological evaluation of indole derivatives. II. Igarashi S; Inami H; Hara H; Fujii M; Koutoku H; Oritani H; Mase T Chem Pharm Bull (Tokyo); 2000 Mar; 48(3):382-8. PubMed ID: 10726862 [TBL] [Abstract][Full Text] [Related]
19. 6-Substituted 3,4-dihydro-naphthalene-2-carboxylic acids: synthesis and structure-activity studies in a novel class of human 5alpha reductase inhibitors. Baston E; Salem OI; Hartmann RW J Enzyme Inhib Med Chem; 2002 Oct; 17(5):303-20. PubMed ID: 12683747 [TBL] [Abstract][Full Text] [Related]
20. Cynanchum wilfordii Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Androgen Receptor Activities in a Rat Model. Lee G; Shin J; Choi H; Jo A; Pan S; Bae D; Lee Y; Choi C Nutrients; 2017 Sep; 9(10):. PubMed ID: 28953224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]